Matthew A. Bill

Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension

Edda Spiekerkoetter, Yon K. Sung, Deepti Sudheendra et al. · European Respiratory Journal · 2017 · 178 citations · Full text

Medicine, Cardiology, Pharmacology +11

Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy

Bethany L. Mundy-Bosse, Gregory Young, Todd M. Bauer et al. · Cancer Immunology Immunotherapy · 2011 · 122 citations

Life Sciences, Immunology, Oncology +17

The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity

Matthew A. Bill, James R. Fuchs, Chenglong Li et al. · Molecular Cancer · 2010 · 115 citations · Full text

Life Sciences, Immunology, Oncology +13

Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines

Matthew A. Bill, Courtney E. Bakan, Don M. Benson et al. · Molecular Cancer Therapeutics · 2009 · 94 citations

Life Sciences, Oncology, Pharmacology +16

PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension

Jan K. Hennigs, Aiqin Cao, Caiyun G. Li et al. · Circulation Research · 2020 · 86 citations · Full text

Medicine, Molecular Biology, Pharmacology +17